Organigram Global Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Organigram Global Inc 's ROA in the third quarter of 2026?
Organigram Global Inc achieved a return on average assets (ROA) of 12.5 % in its third quarter of 2026, this is above OGI's average return on assets of -12.77%.
Organigram Global Inc assets over the 12 months ending in its third quarter of 2026 are valued at $453 million

ROA has improved compared to -5.81% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 249 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from to 3001.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter
Y / Y Total Assets Change	34.05 %	-13.24 %	53.38 %	27.93 %	53.38 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	57	-24	6	-10	-14
Return On Assets (TTM)	12.5 %	-5.81 %	1.41 %	-2.48 %	-3.72 %
OGI's Total Ranking	# 3001	#	#	#	# 3449
Total Assets (TTM) in million	577	374	431	431	431
Seq. Total Assets Change	54.51 %	-13.24 %	0 %	0 %	0 %
Seq. Net Income Change	-	-	-	-	-

OGI's 5 Years Annual ROA >> Back to OGI Management Effectiveness >> Compare OGI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 82
Sector	# 250
Overall	# 2968

Return On Assets Statistics
High	Average	Low
-2.55 %	-12.77 %	-30.32 %
(Aug 31 2022)		(Aug 31 2020)

News about Organigram Global Inc Return on Assets ROA

Karina Gehring Appointed to Organigram's Board of Directors to Enhance Marketing and Brand Management Expertise and Drive Growth

Organigram Welcomes Karina Gehring to the Board of Directors
Organigram Holdings Inc. has recently announced the appointment of Karina Gehring to its Board of Directors. The appointment was made at the company s annual general and special meeting held on January 18, 2024. With her extensive expertise in marketing and brand management, coupled with her ongoing experience at BAT, Gehring s addition to the board is expected to be a tremendous asset.
Peter Amirault, Bo (Board Observer), expressed his enthusiasm on behalf of Organigram, stating, We are thrilled to welcome Karina to our Board of Directors. Gehring s skills and experience will undoubtedly contribute to the company s growth and strategic decision-making processes.

Financial Statements
Organigram Global Inc 's Assets	$ 577 million	OGI's Balance sheet
Organigram Global Inc 's Income	$ 76 million	Quarterly OGI's Income Statement
OGI's Income by Division		See OGI's Income by Division

Annual Return On Assets	(Sep 30 2025) FY 2025	(Sep 30 2024) FY 2024	(Sep 30 2023) FY 2023	(Aug 31 2022) FY 2022	(Aug 31 2021) FY 2021
Y / Y Total Assets Change	27.93 %	38.91 %	-49.44 %	2.47 %	21.57 %
Total Assets in million	431	337	242	479	468
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-19	-33	-11	-11	-103
Annual Return On Assets	-4.4 %	-9.92 %	-4.51 %	-2.34 %	-22.05 %

OGI's 5 Years Annual ROA >> Back to OGI Management Effectiveness >> Compare OGI ROA to its Competitors

More Return On Assets Ratios
OGI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OGI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OGI's Competitors
Subscribers only: Roa for Organigram Global Inc 's Suppliers
Subscribers only: Return On Assets for OGI's Customers

You may also want to know
OGI's Roi	OGI's Inventory Turnover Ratio	OGI's Growth Rates	OGI's Dividend Comparisons
	OGI's Profitability Ratios	OGI's Asset Turnover Ratio	OGI's Dividend Growth
OGI's Roe	OGI's Valuation Ratios	OGI's Financial Strength Ratios	OGI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %

Date modified: 2026-10-15T05:23:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.